Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fampridine plus rehabilitation for upper limb functional restoration in multiple sclerosis
2012-000287-17Phase 2Active
- Sponsor
- Fondazione Santa Lucia IRCCS
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dalfampridine in multiple sclerosis (MS) (3 arms), sponsored by Fondazione Santa Lucia IRCCS. Primary endpoints: Clinical benefit of rehabilitation on right upper limb function and Imaging markers of clinical improvement. Started Jun 2012; status: active.
02
Drugs
dalfampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2012-000287-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000287-17.